VALIDATE Annual Meeting 2024 - Provisional Agenda
Please note that this is a Provisional Agenda and is subject to change. Applications for our latest rounds of Fellowships are still open, and we will be in touch with details of their talks as soon as they are selected.
Day One - Tuesday, 16 July 2024
0900 - 1000 Closed Network Management Board (NMB) & Scientific Advisory Board (SAB) Meeting (Invitation only)
0915 - 1000 Registration & Tea/Coffee
1000 – 1015 Welcome
Prof Helen McShane, VALIDATE Network Director, University of Oxford, UK & Prof Narisara Chantratita, Mahidol University, Thailand
1015 – 1035 VALIDATE Update
Mrs Samantha Vermaak, Co-Investigator & Executive Manager, University of Oxford, UK
Prof Narisara Chantratita, Mahidol University, Thailand
1120 – 1140 Identifying Persister Mycobacterium tuberculosis Biosignatures
Dr Nastassja Kriel, Stellenbosch University, South Africa
Dr Cristian Segura-Cerda, Centro de Investigación y Asistencia en Tecnología y Diseño de Jalisco (CIATEJ), Mexico
1200 – 1300 Lunch
Prof Mary Burtnick, University of Nevada, Reno School of Medicine, USA
1330 – 1350 Alvacc A Human In Vitro Alveolus Model to Study Aerogenic TB Vaccine Binding and Translocation
Dr Diane Lee, University of Surrey, UK
1350 – 1410 Towards a T-cell Subset that can Control Mycobacterium tuberculosis Infection
Dr Munyaradzi Musvosvi, University of Cape Town (UCT), South Africa
1410 – 1430 Evaluation of BCGΔBCG1419cESAT6-PE25SS in Immunocompetent and Immunocompromised Mouse Models of TB
Dr Ana Maria Valencia-Hernandez, James Cook University, Australia
1430 – 1500 The Deletion of Interleukin-4 receptor alpha (IL-4Rα) Signalling on T cells Increased Host Susceptibility to TB
Dr Suraj Parihar, University of Cape Town (UCT), South Africa
1500 – 1530 Afternoon Break
1530 – 1600 Therapeutics Informing Vaccine Development for Human Leishmaniasis
Dr Maria Adelaida Gomez, Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM), Colombia
1600 – 1645 Talks from New VALIDATE Fellows - Titles, abstracts, and speakers to be confirmed soon
1645 – 1700 Day Wrap up
1700 – 1850 Drinks Reception / Poster Session
1850 – 2120 Annual Meeting Dinner
Day Two - Wednesday, 17 July 2024
0900 – 0945 Lessons Learned in BP vs NTM Research
Asst Prof Ganjana Lertmemongkolchai, Chiang Mai University, Thailand
0945 – 1030 Talks from New VALIDATE Fellows - Titles, abstracts, and speakers to be confirmed soon
1030 – 1100 “Mind the Gap” – Bridging Our Knowledge of Animal and Human Tuberculosis
Prof Michele Miller, Stellenbosch University, South Africa
1100 – 1130 Morning Break
1130 – 1145 Innovative Diagnosis for PKDL/Leprosy Project Update
Prof Mitali Chatterjee, Institute of Post-Graduate Medical Education and Research (IPGMER), India
1145 – 1205 Towards a Better TB Vaccine Understanding Improved Local Immune Control by Mucosal BCG Vaccination
Dr Paula Niewold, Leiden University Medical Center (LUMC), Netherlands
1205 – 1225 Testing a Novel, Self-adjuvanting Mucosal Vaccine Candidate for TB in the Mouse Model of Infection
Dr Andy Tran, St George’s University of London (SGUL), UK
1225 – 1245 Characterising the Cytokines Associated with Trained Innate Immunity in BCG Vaccinated Non-human Primates
Dr Laura Sibley, UK Health Security Agency (UKHSA), UK
1245 - 1345 Lunch
1345 – 1415 Exploring the Role of IL-6 in the Risk of Developing TB Disease
Assoc Prof Gabriele Pollara, University College London (UCL), UK
1415 – 1500 Talks from New VALIDATE Fellows - Titles, abstracts, and speakers to be confirmed soon
1500 – 1530 Afternoon Break
1530 – 1600 Defining Correlates of Humoral Immunity Against Inhalational Melioidosis
Prof Paul Brett, University of Nevada, USA;
Prof F. Javier Salguero Bodes, UK Health Security Agency (UKHSA), UK
1630– 1645 Wrap-up and farewell